Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 10, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Status of Robot-Assisted Radical Cystectomy (RARC) in 2012.

Amrith R Rao1, Andrew P Stegemann, Shabnam Rehman

  • 1Department of Urology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263 USA.

Indian Journal of Surgical Oncology
|June 5, 2013
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship between the status of positive surgical margins and biochemical recurrence: developing a risk stratification model for biochemical recurrence following radical prostatectomy.

Journal of robotic surgery·2026
Same author

Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

A virtual cohort framework with applications to adoptive cell therapy in bladder cancer.

bioRxiv : the preprint server for biology·2026
Same author

PETIL: Predicting Expansion of Tumor Infiltrating Lymphocytes for the Adoptive Cell Immunotherapy in Bladder Cancers.

bioRxiv : the preprint server for biology·2026
Same author

Anticancer Efficacy of HPPH-PDT Synergies with BCG-Immunotherapy or COX-2 Inhibitor in Treating Bladder Cancer.

Molecular pharmaceutics·2026
Same author

Does the urinary microbiome reflect the bladder-cancer-associated microbiome? Characterizing the microbiome in urine and cancer tissue in bladder cancer.

Urologic oncology·2026
Same journal

Comparison of Contrast-Enhanced Mammography with MRI for Preoperative Assessment of Breast Cancer: A Pilot Study.

Indian journal of surgical oncology·2026
Same journal

Comparison of Gleason Scoring-2005 and 2014 Updates.

Indian journal of surgical oncology·2026
Same journal

Preventing Nasal Alar Necrosis in Oral Cancer Patients: A Quality Improvement Initiative for Safer Nasotracheal Intubation at a Tertiary Cancer Centre.

Indian journal of surgical oncology·2026
Same journal

Exploring the Skeletal Impact: Androgen Deprivation Therapy and Bone Health in Metastatic Prostate Carcinoma Patients.

Indian journal of surgical oncology·2026
Same journal

Laparoscopic Versus Open Radical Nephrectomy for Renal Cell Carcinoma: A Retrospective Study.

Indian journal of surgical oncology·2026
Same journal

A Single Institution Experience with Pancreatic Carcinoma: A Retrospective Study.

Indian journal of surgical oncology·2026
See all related articles

Robot-assisted radical cystectomy (RARC) offers minimally invasive treatment for bladder cancer, showing comparable oncological and functional outcomes to traditional methods. This approach leads to shorter hospital stays and fewer complications.

Area of Science:

  • Urology
  • Surgical Oncology
  • Robotic Surgery

Background:

  • Robot-assisted radical cystectomy (RARC) is gaining traction globally for bladder cancer treatment.
  • Minimally invasive techniques offer potential advantages in surgical procedures.

Purpose of the Study:

  • To evaluate the oncological and functional outcomes of RARC in bladder cancer patients.
  • To assess the benefits of RARC compared to traditional radical cystectomy.

Main Methods:

  • Review of existing literature and case series on RARC for bladder cancer.
  • Analysis of oncological (cancer control) and functional (urinary diversion) outcomes.
  • Comparison of perioperative data including blood loss, hospital stay, and complications.
Keywords:
Bladder CancerMinimally Invasive SurgeryRadical CystectomyRobot-AssiteddaVinci

Related Experiment Videos

Last Updated: May 10, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Main Results:

  • Mature data demonstrate equivalent medium-term oncological and functional results for RARC.
  • RARC is associated with reduced blood loss, fewer transfusions, and shorter hospital stays.
  • A trend towards decreased complication rates has been observed with RARC.

Conclusions:

  • RARC is a feasible and effective treatment option for bladder cancer, offering comparable outcomes to open surgery.
  • The benefits of RARC include improved patient recovery and potentially fewer complications.
  • Future advancements are expected to further enhance the efficiency and patient benefits of RARC.